|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.1 HKD | +0.92% |
|
+22.22% | -51.54% |
| May. 02 | Non-Executive Director Increases Shareholding in CStone Pharma; Shares Surge 25% | MT |
| Apr. 29 | Cstone Pharmaceuticals’ CEO Boosts Stakeholding | MT |
CStone Pharmaceuticals reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was CNY 463.84 million compared to CNY 481.36 million a year ago. Net loss was CNY 367.23 million compared to CNY 902.68 million a year ago.
Basic loss per share from continuing operations was CNY 0.29 compared to CNY 0.77 a year ago. Diluted loss per share from continuing operations was CNY 0.29 compared to CNY 0.77 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -51.54% | 179M | |
| -1.43% | 104B | |
| +8.96% | 105B | |
| +4.40% | 22.94B | |
| -12.15% | 22.34B | |
| -4.36% | 19.25B | |
| -39.98% | 17.08B | |
| -10.04% | 16.96B | |
| +6.79% | 14.16B | |
| +38.61% | 12.63B |
CSTONE PHARMACEUTICALS 
